Skip to Main Content

Paper Details

Acquired Secondary HER2 Mutations Enhance HER2/MAPK Signaling and Promote Resistance to HER2 Kinase Inhibition in Breast Cancer.
Cancer Res
4
2023
Author NameAffiliation
Jens MeilerInstitute for Drug Discovery, Leipzig University Medical School
Jens MeilerDepartment of Chemistry and Center for Structural Biology, Vanderbilt University
  • 1 - 2

Datasets

Release 1.2